The Center for Professional Advancement, New Brunswick, NJ
November 5-8, 2007
Who Should Attend:
This broadly based course is intended for all scientists and technologists concerned with the development and processing of tablets, capsules and similar products, and with related drug regulatory affairs.The material will be presented in such a way as to be of value to a varying level of expertise. This course will especially benefit those in: Quality Assurance
Marketing
Validation
Purchasing
R&D
Regulatory Affairs
Manufacturing/Production
Engineering Support
Note: Persons seeking an in-depth treatment of only one or two of the major topics of this broadly based program may wish to consider alternative, more specialized courses offered by CfPA in this area of technology.
Description:
The main aim of this course is to review the science relating to tabletted and encapsulated pharmaceutical products. The course begins with a consideration of raw material testing and the basic aspects of powder and granulation technology, progresses through formulation of solid dosage forms to manufacturing processes and equipment including scale-up and technology transfer. The program concludes with key aspects of the evaluation of finished products and the regulatory constraints that must be considered at each stage. Formal sessions of the course are supplemented with informal discussion periods between lecturers and course participants and problem-solving sessions are held on both an open and private basis.
|
|